4//SEC Filing
PHARMACEUTICAL PRODUCT DEVELOPMENT INC 4
Accession 0001219890-11-000005
CIK 0001003124operating
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 9:14 AM ET
Size
7.5 KB
Accession
0001219890-11-000005
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Disposition to Issuer
Common Stock
2011-12-05$33.25/sh−1,139$37,872→ 0 total - Disposition to Issuer
Stock Options (to buy)
2011-12-05−9,095→ 0 totalExercise: $28.52→ Common Stock (9,095 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Pharmaceutical Prodcut Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc. dated as of October 2, 2011, on the effective date of the merger contemplated by the Agreement (the "Merger"), each of these shares of common stock was automatically converted into the right to receive $33.25.
- [F2]These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeoperating
IncorporatedNC
Related Parties
1- filerCIK 0001003124
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 9:14 AM ET
- Size
- 7.5 KB